Myriad Genetics announced that results of a new validation study of the company's polygenic risk score for breast cancer were presented at the 2019 San Antonio Breast Cancer Symposium. "The key finding is that the PRS significantly improves the precision and accuracy of breast cancer risk estimates for women of European ancestry who have pathogenic variants in high- and moderate-penetrance breast cancer genes," the company said in a statement. "Our goal is to help women understand their risk of breast cancer so that they can take steps to live longer, healthier lives. Women who have a family history of breast cancer should consider hereditary cancer testing with the myRisk Hereditary Cancer test," said Jerry Lanchbury, Ph.D., chief scientific officer of Myriad Genetics. "In this landmark study, we demonstrated that for women who test positive for a mutation in one of the five most common breast cancer genes, there are additional genetic factors called single nucleotide polymorphisms that can further influence their lifetime risk of breast cancer."

Tutor Perini released a statement in reaction to a jury verdict in favor of the plaintiff in the case of Washington State Department of Transportation v. Seattle Tunnel Partners, a trial conducted in the Thurston County District Court in the state of Washington. The company said, "Tutor Perini is disappointed with the jury's decision and will appeal the verdict in this case, which conflicts directly with the findings of an independent Dispute Review Board's proceedings that were conducted over the course of the project, including a key finding by the DRB that the steel pipe casing unexpectedly encountered by the tunnel boring machine constituted a 'differing site condition.' Over the past several years, Tutor Perini has consistently asserted that the Company owed compensation for substantial costs incurred as a result of that unexpected encounter and the subsequent delays and repairs that ensued. The Company is reviewing today's decision to evaluate any potential financial impact on the Company and will provide any required disclosure once that evaluation has been completed. A separate court trial in King County, Washington pertaining to the pursuit of associated claims against insurance policies that covered the project is expected to occur in the latter part of next year or in 2021."

Weatherford announced that it has completed its financial restructuring and emerged from chapter 11 protection. The company emerges with a stronger financial foundation having reduced approximately $6.2B of outstanding funded debt, secured $2.6B in exit financing facilities, including a $450M revolving credit facility, secured a $195M letter of credit facility, and secured over $900M of liquidity. Weatherford expects its newly issued ordinary shares will initially resume trading on the OTC Markets with the company ultimately planning to transition trading to the New York Stock Exchange, subject to the receipt of applicable approvals. The transition to the New York Stock Exchange is expected to occur after the company reports results for its fourth quarter ending December 31, holds an investor call, and completes the fresh-start accounting process, which are expected to be completed by early March.

In an interview on CNBC's Mad Money, Centene CEO Michael Neidorff said: The population we're dealing with knows us and knows what we do - they stick with us... We're the highest in quality and member satisfaction... We're growing significantly... The only way you contain costs with a single-payer system is to withhold service... Americans won't be happy with a single-payer system.

S&P Dow Jones Indices will make the following index adjustments to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 to ensure each index more appropriately represents its market capitalization range. The changes will be effective prior to the open of trading on Monday, December 23 to coincide with the December re-balance. Live Nation Entertainment (LYV), Zebra Technologies (ZBRA), and Steris (STE) will move to the S&P 500, switching places with Affiliated Managers Group (AMG), TripAdvisor (TRIP), and The Macerich Co. (MAC), respectively. All companies moving to the S&P 500 have market capitalizations above $12B, and all companies moving to the S&P MidCap 400 have market capitalizations below $4.5B. Grand Canyon Education (LOPE) and Lear (LEA) will replace Oasis Petroleum (OAS) and Southwestern Energy (SWN) in the S&P MidCap 400 respectively. Oasis Petroleum and Southwestern Energy will replace Unit Corp. (UNT) and Frontier Communications (FTR) in the S&P SmallCap 600. Oasis Petroleum and Southwestern Energy are more representative of the small-cap market space, while Unit and Frontier Communications are no longer representative of the small-cap market space. Arrowhead Pharmaceuticals (ARWR) will switch places with Granite Construction (GVA) in the S&P MidCap 400. Arrowhead Pharmaceuticals has a market capitalization more representative of the mid-cap market space, and Granite Construction has a market capitalization more representative of the small-cap market space.

In an interview on CNBC's Mad Money, Anaplan CEO Frank Calderoni said: We've had four quarters since the IPO where we've been able to grow the top and bottom lines... Digitization has really started to accelerate and it's driving our results... We're increasing the number of new customers and current customers are spending more with us... The new world is all about real-time planning.. Over the next five years there's going to be a dramatic shift in planning.

In a regulatory filing, Harmonic disclosed that its CFO Sanjay Kalra sold 28K shares of common stock on December 11th. The total transaction size was $229K.

Horizon Pharma up 9.6% to $36.00 after FDA unit supports use of teprotumumab

Amarin rises 1.4% to $24.46 after resuming trading

Arrowhead to replace Granite Construction in S&P 400 at open on 12/23

Oasis Petroleum (OAS) and Southwestern Energy (SWN) will replace Unit Corp. (UNT) and Frontier Communications (FTR) in the S&P SmallCap 600.